Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04740593
NA

The Effect of Early Glasses on the Development of Amblyopia

Sponsor: Erasmus Medical Center

View on ClinicalTrials.gov

Summary

In a randomized controlled trial, we will establish whether early glasses for high refractive error at age one reduce the development of amblyopia between age one and four. As a secondary outcome early literacy will be compared in groups with and without glasses.

Official title: The Early Glasses Study: Can Early Glasses Prevent the Development of Amblyopia in Children With High Refractive Errors at Age One

Key Details

Gender

All

Age Range

12 Months - 18 Months

Study Type

INTERVENTIONAL

Enrollment

601

Start Date

2021-05-10

Completion Date

2026-03-31

Last Updated

2025-08-11

Healthy Volunteers

Yes

Interventions

OTHER

Orthoptic care with the prescription of glasses from age 12-18 months onwards

Children assigned to the intervention group (group 1) will receive orthoptic care, including exams 1-3 (depending on the refractive error) times a year, and glasses, based on accurate determinations of refractive error by retinoscopy in cycloplegia by the study orthoptists at age 12-18 months. The spectacles for the children in this study will be provided by the study via their optician without costs.

OTHER

Orthoptic care without the prescription of glasses from age 12-18 months onwards

Children with high refractive error in the control group (group 2) will also receive orthoptic care, including exams 1-3 (depending on the refractive error) times a year, but they will not receive glasses.

OTHER

First measurement only

Children who have no or mild refractive error (group 3), the majority of all children, will be examined by the study orthoptists only once at the age of 12-18 months, after which youth health care (YHC) physicians and nurses will continue standard vision screening at CHCs, as part of screening for general health disorders and vaccinations. Visual acuity is measured routinely at 42-48 months as part of standard vision screening.

Locations (1)

Dept. of Ophthalmology Erasmus Medical Center

Rotterdam, Netherlands